Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TDM-105795 by Technoderma Medicines for Androgenic Alopecia: Likelihood of Approval
TDM-105795 is under clinical development by Technoderma Medicines and currently in Phase II for Androgenic Alopecia. According to GlobalData, Phase...